The nicotinamide adenine dinucleotide (NAD+ )/reduced NAD+ (NADH) and NADP+/reduced NADP+ (NADPH) redox couples are essential for maintaining cellular redox homeostasis and for modulating numerous biologic
The nicotinamide adenine dinucleotide (NAD+ )/reduced NAD+ (NADH) and NADP+/reduced NADP+ (NADPH) redox couples are essential for maintaining cellular redox homeostasis and for modulating numerous biologic
Hypertension is a major global health concern, linked to millions of deaths due to cardiovascular issues. It involves endothelial dysfunction and arterial stiffness, contributing to atherosclerotic diseases. Improving va
High-sugar diets have led to a rising prevalence of various chronic illnesses, including obesity, diabetes, cardiovascular diseases, and hypertension, posing a significant global public health concern. Stevia Rebaudiosid
CFS is a disorder of unknown etiology, consisting of prolonged, debilitating fatigue, and a multitude of symptoms including neurocognitive dysfunction, flu-like symptoms, myalgia, weakness, arthralgia, low-grade fev
Alcohol is a kind of psychoactive substance, which has been commonly used in several cultures for centuries. Alcohol intake is the main cause of acute liver injury and chronic liver disease. Alcoholism can accelerate man
Stevia (Stevia rebaudiana Bertoni), a perennial shrub of the Compositae family, is cultivated in many regions across the world. It is famous for its sweetness, which is due to the presence of steviol glycosides, having 1
Stevioside is a natural sweetener derived from the stevia plant. It has a high sweetness intensity and low-calorie content, making it attractive for diabetics and others on carbohydrate-controlled diets. However, stevios
Highlight: In chronic HBV infection elevated ROS production is associated to high DNA damage in HBV-specific CD8 T cells - Response to DNA damage is dysfunctional - Up-regulation of CD38 and persistent activatio
In the pass decades days, the Open AI and the amazing founder behind AI application both captured attention world widely. But recently, as MIT Technology Review reported, the OpenAI CEO Sam Altman has turned ou